NFKB1 and hepatocellular carcinoma: All these findings are consistent with our previous studies on unsaturated fatty acids, NF-κB activation, and HCC aggressiveness [10,11,12,17,18], suggesting that therapeutic targeting of fatty acid unsaturation might be effective for selective elimination of liver CSCs [24,25].